September 2, 2025 · Form 4 insider transaction
Paolini John F. bought 1,725 shares of Kiniksa Pharmaceuticals Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.